gp96 autologous heat shock protein
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for gp96 autologous heat shock protein, covering 2020-03-12 to 2020-03-12. Get the full timeline:
Most recent: Clinical Trial Update: A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96 [Phase 2]